Differential sensitivity to cAMP among human cord and maternal/adult peripheral lymphocytes discloses differences between PHA- and OKT3-induced activation pathways
- PMID: 2556345
- PMCID: PMC1385451
Differential sensitivity to cAMP among human cord and maternal/adult peripheral lymphocytes discloses differences between PHA- and OKT3-induced activation pathways
Abstract
Previous studies have demonstrated that human cord blood lymphocytes are resistant to the anti-proliferative action of prostaglandin E2 (PGE2) in phytohaemagglutinin (PHA)-induced mitogenesis, whereas the same cells activated by OKT3 are at least as sensitive to PGE2 as the corresponding cells from their mothers or other adults. In the present investigation it was found that: (i) PHA-induced proliferation of cord peripheral blood mononuclear leucocytes (PBML) is less sensitive to inhibition by forskolin--a direct activator of adenylate cyclase (AC)--and dibutyryl cAMP--a permeant cAMP analogue--than the proliferation of the corresponding maternal cells; (ii) OKT3-induced proliferation of cord as well as maternal PBML is highly sensitive to inhibition by forskolin and dibutyryl cAMP; (iii) cord PBML show an overall lower rate of AC activity compared with maternal PBML, in response to PGE2 and other autacoids as well as to receptor-independent stimulation; (iv) cord PBML also display a significantly lower rate of degradation of cAMP through cAMP-phosphodiesterase compared with maternal cells; (v) unbroken cord and maternal PBML show comparable rates of cAMP accumulation after stimulation with PGE2. The results suggest a lower sensitivity to the effect of cAMP in cord compared with maternal/adult lymphocytes in PHA-induced proliferation. Moreover, the data illustrate differences between PHA- and OKT3-mediated activation pathways, as well as differences in cell regulation mechanisms between cord and maternal PBML.
Similar articles
-
Mitogenic action of phorbol ester TPA and calcium ionophore A23187 on human cord and maternal/adult peripheral lymphocytes: regulation by prostaglandin E2.Clin Exp Immunol. 1987 Oct;70(1):173-81. Clin Exp Immunol. 1987. PMID: 3121221 Free PMC article.
-
Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells.Cell Immunol. 1994 Oct 1;158(1):116-30. doi: 10.1006/cimm.1994.1261. Cell Immunol. 1994. PMID: 8087859
-
Different effect of prostaglandin E2 on B-cell activation by two distinct B-cell differentiation factors, B151-TRF1/IL-5 and B151-TRF2: selective inhibition of B151-TRF2-induced antibody response through increases in intracellular cyclic AMP levels.Immunology. 1989 Oct;68(2):154-62. Immunology. 1989. PMID: 2553585 Free PMC article.
-
Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression.J Immunol. 1985 Aug;135(2):1172-9. J Immunol. 1985. PMID: 2989362
-
cAMP and lectin-induced mitogenesis in lymphocytes: possible implications for neoplastic cell growth.Adv Cyclic Nucleotide Res. 1978;9:647-60. Adv Cyclic Nucleotide Res. 1978. PMID: 208402 Review. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources